Combination of Acupuncture and Hypnotherapy on Blood Pressure Reduction
DOI:
https://doi.org/10.26911/theijmed.2024.09.04.01Abstract
Background: Hypertension is "the silent killer" the number 2 highest cause of death in Indonesia. One of the non-pharmacological therapies that can be used to reduce hypertension is acupuncture and hypnotherapy. This study aims to analyze the effectiveness of the combination of acupuncture and hypnotherapy (hypnotherapy) on lowering blood pressure.
Subjects and Method: The Randomized Controlled Trial (RCT) research was conducted at three clinics, namely Klinki Dr. Singgih, Kusuma Husada Clinic, and Griya Sehat Sinergi from March to September 2023. A total of 160 hypertensive patients were divided into four groups: (1) Acupuncture intervention group (n= 40); (2) Hypnotherapy intervention group (n= 40); (3) Hypnopunk intervention group (n= 40); and (4) The control group was given standard care (n=40). The dependent variable is hypertension. The independent variable was hypnopuncture. The difference in the mean decrease in blood pressure of systole and diastole in each group was analyzed using the ANOVA test.
Results: The mean systole blood pressure was lower in the hypnopuncture group (Mean = 145.43; SD= 3.39) than the acupuncture group (Mean= 154.55; SD= 7.42), hypnotherapy group (Mean= 150.95; SD= 11.92), as well as the control group (Mean= 177.22; SD= 7.87), and this result was statistically significant (p <0.001). The average diastole blood pressure was lower in the hypnopuncture group (Mean = 86.47; SD= 1.57) than the acupuncture group (Mean= 87.25; SD= 10.34), hypnotherapy group (Mean= 87.25; SD= 2.89), as well as the control group (Mean= 95.03; SD= 2.90), and this result was statistically significant (p <0.001).
Conclusion: Hypnopuncture is effective in lowering systole and diastole blood pressure levels in hypertensive patients.
Keywords:
cervical cancer, particopations, screening, womenReferences
Ago B U, Efiok E E, Abeng S E (2022). Sociodemographic and gynecological factors that influence uptake of cervical cancer screening: A cross-sectional study in Calabar, Nigeria. Afr Health Sci. 22(4 PG-96–103):96–103. doi:10.4314/-ahs.v22i4.13.
Akokuwebe M E, Idemudia E S , Lekulo A M , Motlogeloa O W (2021). Deter-minants and levels of cervical cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa Demographic and health survey data, 2016. BMC Public Health. 21(1 PG-2013):2013. doi: 10.1186/s128-89-021-12020-z.
Al-Amro S Q , Gharaibeh M , Oweis A I (2020). Factors associated with cervical cancer screening uptake: implications for the health of women in Jordan. Infect Dis Obstet Gynecol, 2020(PG-9690473): 9690473. doi:10.-1155/2020/9690473.
Alam Z , Ann Dean J and Janda, M (2022). Cervical screening uptake: A cross-sectional study of self-reported screening attitudes, behaviors and barriers to participation among South Asian immigrant women living in Australia. Womens Health (Lond). 18(PG-17455057221096240) doi: 10.1177/17455057221096240.
Amin R, Kolahi AA, Jahanmehr N, Abadi AR , Sohrabi MR (2020). Disparities in cervical cancer screening participation in Iran: across-sectional analysis of the 2016 nationwide STEPS survey. BMC Public Health. 20(1 PG-1594): 1594.doi: 10.1186/s12889-020-09705-2.
Ampofo AG, Adumatta AD, Owusu E, Newton KA (2020). A cross-sectional study of barriers to cervical cancer screening uptake in Ghana: An application of the health belief model. PLoS One. 15(4 PG-e0231459): e0231459. doi: 10.1371/-journal.pone.0231459.
Ba DM, Ssentongo P, Musa J, Agbese E, Diakite B, Traore CB, Wang S, Maiga M (2021). Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study. Cancer Epidemiol. 72(PG-101930): 101930. doi: 10.1016/j.canep.2021.101930.
Bante SA , Getie SA, Getu AA , Mulatu K, Fenta SL (2019). Uptake of pre-cervical cancer screening and associated factors among repro-ductive age women in Debre Markos town, Northwest Ethiopia, 2017. BMC Public Health. 19(1 PG-1102):1102. doi:10.1186/s12889-019-7398-5.
Chan DNS, So WKW (2017). A systematic review of the factors influencing ethnic minority women’s cervical cancer screening behavior: From intrapersonal to policy level. Cancer Nursing. 40(6):E1–E30. doi: 10.10-97/NCC.0000000000000436.
Chandrika K, Naik BN, Kanungo S (2020). Awareness on cancer cervix, willing-ness, and barriers for screening of cancer cervix among women: A community-based cross-sectional study from urban Pondicherry. Indian J Public Health. 64(4 PG-374–380): 374–380. doi: 10.4103/-ijph.IJPH_29_20.
Diendéré J, Kiemtore S, Coulibaly A, Tougri G, Ily N, Kouanda S(2023). Low attendance in cervical cancer screening, geographical disparities and sociodemographic determinants of screening uptake among adult women in Burkina Faso : results from the first nationwide population-based survey. Rev Epidemiol Sante Publique. 71(4 PG-101845): 101845. doi: 10.1016/j.respe.2023.101845.
Donatus L, Nina FK, Sama DJ, Nkfusai CN, Bede F, Shirinde J, Cumber SN (2019). Assessing the uptake of cervical cancer screening among women aged 25-65years in Kumbo West Health District, Cameroon. Pan Afr Med J. 33(PG-106):106. doi: 10.11604/pamj.2019.33.106.16975.
Fentie AM, Tadesse TB, Gebretekle G B (2020). Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia. BMC Womens Health. 20(1 PG-147):147. doi: 10.1186/s12905-020-01008-3.
Gelassa FR, Nagari SL, Jebene DE, Belgafo D, Teso D, Teshome D (2023). Knowledge and practice of cervical cancer screening and its associated factors among women attending maternal health services at public health institutions in Assosa Zone, Benishangul-Gumuz, Northwest Ethiopia, 2022:a cross-sectional study. BMJ Open, 13(5 PG-e068860): e068860. doi: 10.1136/-bmjopen-2022-068860.
Gemeda EY, Kare BB, Negera DG, Bona LG, Derese BD, Akale NB, Kebede KM, Koboto DD, Tekle AG (2020). Prevalence and predictor of cervical cancer screening service uptake amongwomen aged 25 years and above in Sidama Zone, Southern Ethiopia, usinghealth belief model. Cancer Control. 27(1 PG-1073274820954460). doi: 10.1177/-1073274820954460.
Ibeanu O A (2011). Molecular Pathogenesis of Cervical Cancer. Cancer Biology and Therapy. 11(3): 295–306.
Isabirye A (2022). Individual and intimate-partner factors associated with cervical cancerscreening in Central Uganda. PLoS One. 17(9 PG-e0274602): e0274602. doi: 10.13-71/journal.pone.0274602.
Natae SF, Nigatu DT, Negawo MK, Mengesh WW (2021). Cervical cancer screening uptake and determinant factors among women in Ambo town, Western Oromia, Ethiopia: Community-based cross-sectional study. Cancer Med. 10(23 PG-8651–8661):8651–8661. doi: 10.1002/cam4.4369.
Novalia V (2023). Kanker Servik. GALENICAL : Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh. 2(1): 45.
Phaiphichit J, Paboriboune P, Kunnavong S , Chanthavilay P (2022). Factors associated with cervical cancer screening among women aged 25-60years in Lao People’s Democratic Republic. PLoS One. 17(4 PG-e0266592): e0266592. doi:10.1371/journal.pone.0266592.
Maria SN, Olwit C, Kaggwa MM, Nabirye RC, Ngabirano TD (2022). Cervical cancer screening among HIV-positive women in urban Uganda: across sectional study. BMC Womens Health. 22(1 PG-148):148. doi: 10.1186/s12905-022-01743-9.
Sung H (2021). Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinicians. 71(3):49–209.
Wakwoya EB, Sadi CG, Sendo EG (2023). Precancerous cervical lesion screening acceptance among women in EasternEthiopia. BMJ Open. 13(11 PG-e073721): e073721. doi: 10.1136/bmjopen-2023-073721.
Weng Q, Jiang J , Haji F M,Nondo L H, Zhou H (2020). Women’s knowledge of and attitudes toward cervical cancer and cervicalcancer screening in Zanzibar, Tanzania: a cross-sectional study. BMC Cancer. 20(1 PG-63): 63. doi: 10.1186/s12885-020-6528-x.
